About Regulator of G-protein signaling 20
Regulator of G-protein signaling 20 (RGS20) is a protein
from Homo sapiens identified by UniProt accession
O76081, 388 residues long.
MolForge cross-references it against 0 known binders and
40 disease associations.
Target properties
| Protein name | Regulator of G-protein signaling 20 |
| UniProt accession | O76081 |
| Gene | RGS20 |
| Organism | Homo sapiens |
| Length | 388 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (40)
Diseases linked to this target (Open Targets).
- beta-secretase 1 measurement · score 0.19
- non-small cell lung carcinoma · score 0.08
- pachyonychia congenita · score 0.07
- renal cell carcinoma · score 0.07
- age at first sexual intercourse measurement · score 0.05
- neoplasm · score 0.05
- high density lipoprotein cholesterol measurement · score 0.04
- sleep duration · score 0.04
- cerebrospinal fluid biomarker measurement · score 0.03
- hepatocellular carcinoma · score 0.03
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O76081-F1 | alphafold | PREDICTED | 61.80 | — |
Amino-acid sequence (388 residues)
MPQLSQDNQE CLQKHFSRPS IWTQFLPLFR AQRYNTDIHQ ITENEGDLRA VPDIKSFPPA QLPDSPAAPK LFGLLSSPLS SLARFFSHLL RRPPPEAPRR RLDFSPLLPA LPAARLSRGH EELPGRLSLL LGAALALPGR PSGGRPLRPP HPVAKPREED ATAGQSSPMP QMGSERMEMR KRQMPAAQDT PGAAPGQPGA GSRGSNACCF CWCCCCSCSC LTVRNQEDQR PTIASHELRA DLPTWEESPA PTLEEVNAWA QSFDKLMVTP AGRNAFREFL RTEFSEENML FWMACEELKK EANKNIIEEK ARIIYEDYIS ILSPKEVSLD SRVREVINRN MVEPSQHIFD DAQLQIYTLM HRDSYPRFMN SAVYKDLLQS LSEKSIEA
Explore Regulator of G-protein signaling 20 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets